Φορτώνει......
The role of dexlansoprazole modified-release in the management of gastroesophageal reflux disease
Dexlansoprazole modified-release (MR) is the R-enantiomer of lansoprazole and is currently the only proton-pump inhibitor (PPI) with a novel dual delayed release (DDR) formulation. Overall, dexlansoprazole MR demonstrates a similar safety and side-effect profile as lansoprazole. Dexlansoprazole MR h...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Therap Adv Gastroenterol |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
SAGE Publications
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5298478/ https://ncbi.nlm.nih.gov/pubmed/28203282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X16681701 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|